We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Xaar Plc | XAR | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 120.00 | 11:09:04 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 120.00 |
| Industry Sector |
|---|
| TECHNOLOGY HARDWARE & EQUIPMENT |
| Top Posts |
|---|
Posted at 15/1/2024 07:10 by amt Xaar seems to have very favourable sentiment towards it and strong support from investors. |
Posted at 02/12/2023 11:32 by darrin1471 If there had not been better opportunities elsewhere, I would of probably of bought below 170 for a 20% bounce or for a multi year holding.This weeks trading update is a shocking turn around in the 2024 prospects. Progressive research have cut their 2024 full year PBT from 4.2m to 0.4m. It's a must read for any small investor or anybody looking at XAAR: With little prospect of a turn around in outlook for 6 months, then some holders are likely to sell and who is going to buy at the current price. XAAR may become a target of short sellers given its high valuation. I still like the medium/long term XAAR story but now expect to see a better entry point in the future. I hold no long or short position in XAR |
Posted at 25/1/2023 01:46 by simmsc "Progressive Equity Research" has written a 16 page detailed analysis on XAAR, focusing on the technology. They highlight how the structure and design of Xaar's printheads provide competitive advantages in overcoming the key challenges faced in several of the areas that make up the company's USD 1 billion addressable market opportunity. I've skimmed over it briefly tonight and will read in more detail over the weekend. This looks to have been written to help investors better understand where XAARS competitive advantages are (and why). Looks interesting. I am a holder, running a slight loss at the moment, and will be adding when the upward momentum picks up again on the share price |
Posted at 15/7/2022 09:44 by se81 and more commentary from Progressive today after the update yesterday (Paid for "research" of course but a good way for the co to communicate with investors outside scheduled updates)Xaar’s H1 trading update for 6M ended 30th June 2022, issued yesterday, confirms that the group is trading well, with increased revenues, improving margins, costs under control and new products launching to schedule. Xaar is clearly back onto a robust growth trajectory. We are maintaining our forecasts and look forward to the interims in September as an opportunity find out more about how the momentum is building. ▪ Revenues and profits growth in line with expectations - The statement confirms that after a strong H1, performance for the full year at PBT level is seen as being in line with expectations. Revenues for H1 are expected to be approx. £37m – 41% up YoY and 14% up on an organic basis before the FFEI and Megnajet. The strong revenue growth has been accompanied by increased gross margins and effective actions on costs. ▪ Investment continues – Net Cash as at 30th June was £12.6m, down from the year end figure of £15.3m. This is consistent with our forecasts, given the acquisition of Megnajet, the ongoing capital investments and the requirement to increase working capital to protect Xaar from supply chain issues and to ensure that customers’ requirements are met. ▪ Trading encouraging on all fronts - The core printhead division has traded well, with European and US growth offsetting the Covid related slowdown in China. The product print business, eps, has seen both revenue and margin growth. ▪ Product development going to plan - The statement confirms that not only has trading performance been good, but so has progress with new product development. A new printbar product was launched in H1 by FFEI, but most importantly the company remains on track to launch the much-anticipated aqueous printhead product in Q4 2022. ▪Price increases, not just cost cutting - The statement refers to management actions to mitigate the impact of cost increases – not least of which is the fact that Xaar has successfully put through sales price increases. This is a timely and reassuring reminder that it has products, skills and technologies that customers value and are willing to pay up for. Xaar offers investors a clear, understandable tech growth story with a near $1bn addressable market opportunity and a management team that is demonstrating its ability to execute. We continue to question whether the value of this combination is fully reflected in the share price. |
Posted at 22/6/2022 07:43 by se81 Progressive out with a new (free) note this morning....some interesting stuff in there (re the business, products, future growth etc)- headline summary belowWith a clear roadmap of new digital inkjet products and an ambitious management team focused on gaining (or retaining) significant market shares across the segments that make up its $1bn addressable market, Xaar is positioned to grow strongly. Management has already demonstrated its abilities in turning the business around, and we believe it is far from clear that the share price fully reflects the opportunities ahead. ▪ $1bn market awaits. The market for industrial digital inkjet printheads is estimated by management to be approaching $1bn per annum. Xaar’s product roadmap suggests that it will be able to address the vast majority of this within a few years. If the management team delivers on the product roadmap, Xaar will be well-positioned to take a strong share of these markets. ▪ Clear signs of progress. Management has a strategy in place to drive revenue back up by launching new products and adopting a revised approach to customers and the channel. Improving revenues and a growing number of customer products both in development and in the market show that management is already delivering on this strategy. ▪ Profit and cashflow upside. The high gross margin and relatively fixed cost base mean that as product and revenue traction build, the impact on the bottom line will be geared upwards. On top of this, the significant historical capital investment means that material increases in output can be achieved for limited capital outlay: a possible positive profit and cashflow double whammy. ▪ ESG potential. Management believes that Xaar can reduce overall ink and energy consumption, most notably with the launch of its aqueous ink capable printheads, which use significantly less water than standard printheads and save on the heat energy used to dry the inks. Starting from £40m revenue in printheads in FY21, a near $1bn addressable market opportunity and a management team that has shown itself able to execute, even though the shares are on premium multiples, the market valuation appears that it may not fully reflect the scale of Xaar’s potential revenue and profit growth. Xaar offers investors a clear, understandable technology growth story, building on an established set of technologies providing solutions across a range of demanding printing applications. |
Posted at 11/4/2022 13:56 by johnv The reason CR tells he likes it is because his pool of investors have bought it and he is now ramping it up. |
Posted at 23/11/2021 08:40 by ny boy Jb I’m a long term investor, using the opportunity to add more AO. And soon here, I am a fan of XAR attractive to a predator as well, look into Q2+ 2022Jb do you actually buy stocks or just go around stalking other investors, a strange person? |
Posted at 16/9/2021 07:24 by zho Simon Thomson in Investors' Chronicle:The price has since pulled back close to my last entry point (185p) on profit taking which means that Xaar is now rated on an enterprise valuation to cash profit multiple of 9 for 2023, hardly excessive for a recovery stock. I am tweaking my target up slightly from 220p to 230p and continue to rate the shares a buy. (Search on text to access whole article) |
Posted at 12/8/2021 18:34 by napoleon 14th alter ego - right other than Richard had a bust-up with ADVFN who would do nothingabout the trolls polluting is thread here. The serious investors agreed with him & we migrated to Slack, where numbers aree limited to 280 members. There were 5 seats vacant for 55 applicants last Jan 1st. The last two were auctioned & the proceeds, some £10K, went to GOSH (Great Ormond Street Hospital). I'm not one for hero worship but renew every year without fail because of results, so it's a "good contract". mrnumpty - I started surfing fin sites on Sharecrazy, so thought this was fun for one who is half French such as I... |
Posted at 11/8/2021 00:56 by dougmachin I normally only buy:- SCSW Growth Portfolio stocks. - Ones where the SCSW writer (editor) has a declared holding (normally has an * at the end of the write-up). This is different to the just "we're buyers". - Where directors are buying heavily or there's a significant buy back, like TRMR. - Where there's a bigger picture growth story, like RCH, VLX, MNZS, ATG (didn't see this with Esken) or KMK (which SCSW actually gave up on). - Where other experienced investors (PiWorld / following on Twitter / Mello presentations / IC etc etc) are kind of cross correlating the story. - Go in smaller at the start and then buy the dips if the story seems to get better, maybe at a higher price. There always seems to be significant dips. Apologies for off topic and I am far from good at this, but this seems to be working for me, so far! I first subscribed to SCSW about 16 years ago (with HSP the first time around). |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
